Stay updated on PI3Kinase Inhibition and Nivolumab in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the PI3Kinase Inhibition and Nivolumab in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PI3Kinase Inhibition and Nivolumab in Solid Tumors Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A site-wide banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-24T13:23:51.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision label changes from v3.7.1 to v3.7.2; the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T13:30:51.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The site footer’s revision identifier changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-10T14:24:04.000Z thumbnail image
  4. Check
    35 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error instead of the study details, indicating the content is blocked from access. This reflects a change in accessibility rather than the study data itself.
    Difference
    21%
    Check dated 2026-09-19T20:34:09.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    The page shows a new revision number in the footer, updating from v3.6.5 to v3.6.6, which indicates a backend or frontend update without content changes.
    Difference
    0.1%
    Check dated 2026-08-29T18:48:54.000Z thumbnail image
  6. Check
    78 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.4 to v3.6.5, indicating a minor maintenance update to the page version. No study content or data were changed.
    Difference
    0.0%
    Check dated 2026-08-08T11:45:02.000Z thumbnail image

Stay in the know with updates to PI3Kinase Inhibition and Nivolumab in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PI3Kinase Inhibition and Nivolumab in Solid Tumors Clinical Trial page.